Cite
Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis.
MLA
Ma, Jianglei, et al. “Head-to-Head Comparison of Prostate-Specific Membrane Antigen PET and Multiparametric MRI in the Diagnosis of Pretreatment Patients with Prostate Cancer: A Meta-Analysis.” European Radiology, vol. 34, no. 6, June 2024, pp. 4017–37. EBSCOhost, https://doi.org/10.1007/s00330-023-10436-2.
APA
Ma, J., Yang, Q., Ye, X., Xu, W., Chang, Y., Chen, R., Wang, Y., Luo, M., Lou, Y., Yang, X., Li, D., Xu, Y., He, W., Cai, M., Cao, W., Ju, G., Yin, L., Wang, J., Ren, J., … Ren, S. (2024). Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis. European Radiology, 34(6), 4017–4037. https://doi.org/10.1007/s00330-023-10436-2
Chicago
Ma, Jianglei, Qinqin Yang, Xiaofei Ye, Weidong Xu, Yifan Chang, Rui Chen, Ye Wang, et al. 2024. “Head-to-Head Comparison of Prostate-Specific Membrane Antigen PET and Multiparametric MRI in the Diagnosis of Pretreatment Patients with Prostate Cancer: A Meta-Analysis.” European Radiology 34 (6): 4017–37. doi:10.1007/s00330-023-10436-2.